Compare BIO-TECHNE Corp (TECH) vs TKO Group Holdings Inc (TKO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BIO-TECHNE Corp vs TKO Group Holdings Inc — how do they compare? BIO-TECHNE Corp trades at $71.63 (market cap $11.16B), while TKO Group Holdings Inc trades at $181.83 (market cap $13.70B). The key difference: TKO Group Holdings Inc is the larger of the two by market cap, and TKO Group Holdings Inc pays the higher dividend (1.7%). Which is the better fit depends on your goals.
| TECH | TKO | |
|---|---|---|
Market Cap | $11.16B | $13.70B |
Sector | Health | Technology |
52-Week High | $72.12 | $224.96 |
52-Week Low | $43.31 | $155.61 |
Enterprise Value | $11.24B | $17.88B |
Dividend Yield | 0.45% | 1.7% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio-Techne (TECH) trades at $71.64, down 0.67% today, near its 52-week high following Merck KGaA's $73 per share acquisition offer. The stock shows bullish technical signals with strong moving averages, though RSI indicates overbought conditions. Recent earnings have been mixed, with Q4 2025 beating expectations but Q1 2026 missing. The company maintains solid gross margins of 64.96% but faces declining net income margins, down to 6.01% in 2025 from 25.09% in 2023.
The outlook is heavily influenced by the pending acquisition, offering a clear exit near current levels. Risks include shareholder litigation over deal fairness and fundamental profitability pressures. With a high P/E of 103.03, the stock's upside appears capped without the deal, while the $73 bid provides a near-term floor. Investors should weigh acquisition completion probability against operational challenges.
TKO trades at $182.79, down 1.26% today, with a bearish technical signal despite strong analyst support. The company shows solid revenue growth with 2026 projections at $5.1B and improved net profit margin of 4.47%. Recent developments include successful international events and an $800 million share repurchase, while earnings have been mixed with Q1 2026 beating expectations but Q3 and Q4 2025 missing.
Wall Street remains bullish with 89% buy ratings and a $228.40 consensus price target, representing 25% upside potential. Key risks include execution on earnings expectations and high valuation multiples. The stock presents a growth opportunity driven by live event demand and media partnerships, though investors should monitor quarterly performance against elevated expectations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →About TKO Group Holdings Inc
TKO Group Holdings is a premium sports and entertainment company that serves as the parent entity for the Ultimate Fighting Championship (UFC) and World Wrestling Entertainment (WWE). Formed through a seismic merger orchestrated by Endeavor, TKO leverages a combined global fanbase of over 1 billion to drive massive revenue through media rights, global live events, and a unified sponsorship platform, effectively monopolizing the professional combat sports landscape.
Read more on TKO →
